2,522
Views
3
CrossRef citations to date
0
Altmetric
Articles

Quality of life in patients with nonvalvular atrial fibrillation treated with oral anticoagulants

, , , , , & ORCID Icon show all

References

  • Kannel W, Wolf P, Benjamin E. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82(8A):2N–9N.
  • Lane DA, Skjøth F, Lip GYH, et al. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. J Am Heart Assoc. 2017;6:e005155.
  • Hankey GJ. Stroke treatment and prevention. An evidence-based approach. Cambridge: Cambridge University Press; 2005.
  • Kovacs RJ, Flaker GC, Saxonhouse SJ, et al. Practical management of anticoagulation in patients with atrial fibrillation. J Am Coll Cardiol. 2015;7(65):1340–1360.
  • Arribas Ynsaurraiga F, Peinado Peinado R, Ormaetxe Merodio JM. Atrial fibrillation and quality of life related to disease and treatment: focus on anticoagulation. Future Cardiol. 2014;10(3):381–393.
  • Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334(13):835–840.
  • Bergner M. Quality of life, health status, and clinical research. Med Care. 1989;27:S148–S156.
  • Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis. 2000;9:283–292.
  • López-López JA, Sterne JAC, Thom HHZ, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. Br Med J. 2017 Nov 28;359:j5058.
  • Orueta JF, Nuño-Solinis R, Mateos M, et al. Monitoring the prevalence of chronic conditions: which data should we use? BMC Health Serv Res. 2012;12:365.
  • Garrison LP, Neumann PJ, Erickson P, et al. Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report. Value Health. 2007;10:326–335.
  • Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433–441.
  • Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–272.
  • Badía X, Roset M, Montserrat S, et al. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112(supl 1):S79–S86.
  • Brazier J, Deverill M, Green C, et al. A review of the use of health status measures in economic evaluation. Health Technol Asses. 1999;3(9):i–iv. 1–164.
  • Ramos-Goñi JM, Craig BM, Oppe M, et al. Handling data quality issues to estimate the Spanish EQ-5D-5L value set using a hybrid interval regression approach. Value Health. 2018;21:596–604.
  • Arrospide A, Ramos-Goñi JM, Pechlivanoglou P, et al. Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models. Gac Sanit. 2020; 34:91–95.
  • López-Nicolás Á, Trapero-Bertran M, Muñoz C. Smoking, health-related quality of life and economic evaluation. Eur J Health Econ. 2018;19:747–756.
  • Huang IC, Frangakis C, Atkinson MJ, et al. Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health Serv Res. 2008;43:327–339.
  • Arrospide A, Machón M, Ramos-Goñi JM, et al. Inequalities in health-related quality of life according to age, gender, educational level, social class, body mass index and chronic diseases using the Spanish value set for Euroquol 5D-5L questionnaire. Health Qual Life Outcomes. 2019;17(1):69.
  • Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507–1515.
  • Rapkin BD, Schwartz CE. Advancing quality-of-life research by deepening our understanding of response shift: a unifying theory of appraisal. Qual Life Res. 2019;28:2623–2630.
  • Matchar DB, Samsa GP, Cohen SJ, et al. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial. Am J Med. 2002;113:42–51.
  • Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis. 2000;9:283–292.
  • Contreras Muruaga MM, Vivancos J, Reig G, et al. Satisfaction, quality of life and perception of patients regarding burdens and benefits of vitamin K antagonists compared with direct oral anticoagulants in patients with nonvalvular atrial fibrillation. J Comp Eff Res. 2017;6:303–312.
  • Kulinna W, Ney D, Wenzel T, et al. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thromb Hemost. 1999;25:123–126.
  • Mani H, Lindhoff-Last E. New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness. Drug Des Devel Ther. 2014 Jun 17;8:789–798.
  • Prins MH, Guillemin I, Gilet H, et al. Scoring and psychometric validation of the perception of anticoagulant treatment questionnaire (PACT-Q). Health Qual Life Outcomes. 2009;7:30.